I agree that this site is using cookies. You can find further informations here.
X
Yokoyama, Toshihide
209  results:
Search for persons X
?
1

Tepotinib‐induced hand‐foot skin reaction:

Yamano, Takafumi ; Yokoyama, Toshihide ; Ishida, Tadashi
Respirology Case Reports.  12 (2024)  5 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
2

A single arm Phase I/II trial on the combination of carbopl..:

Nogami, Naoyuki ; Kubo, Toshio ; Bessho, Akihiro...
Japanese Journal of Clinical Oncology.  54 (2024)  7 - p. 805-812 , 2024
Link: https://doi.org/10.1093/..
 
?
3

The Tumor Immune Microenvironment Is Associated With Recurr..:

Kanemura, Hiroaki ; Yokoyama, Toshihide ; Nakajima, Ryu...
JTO Clinical and Research Reports.  5 (2024)  4 - p. 100658 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Impacts of probiotics on the efficacies of immune checkpoin..:

Morita, Ayako ; Ichihara, Eiki ; Inoue, Koji...
International Journal of Cancer.  154 (2024)  9 - p. 1607-1615 , 2024
Link: https://doi.org/10.1002/..
 
?
5

Machine learning analysis of pathological images to predict..:

Shibaki, Ryota ; Fujimoto, Daichi ; Nozawa, Tsukasa...
Journal for ImmunoTherapy of Cancer.  12 (2024)  2 - p. e007987 , 2024
Link: https://doi.org/10.1136/..
 
?
6

A Retrospective, Multicenter, Observational Study to Evalua..:

Goto, Yasushi ; Kenmotsu, Hirotsugu ; Tamiya, Motohiro...
JTO Clinical and Research Reports.  4 (2023)  5 - p. 100508 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Corrigendum to "Osimertinib as first-line treatment for eld..:

Sakata, Yoshihiko ; Saito, Go ; Sakata, Shinya...
Lung Cancer.  , 2023
Link: https://doi.org/10.1016/..
 
?
8

Exploratory analysis of immunochemotherapy compared to chem..:

Hata, Tae ; Sakaguchi, Chikara ; Hirano, Keita...
Thoracic Cancer.  14 (2023)  11 - p. 1004-1011 , 2023
Link: https://doi.org/10.1111/..
 
?
9

A randomized phase II study of afatinib alone or combined w..:

Ninomiya, Takashi ; Ishikawa, Nobuhisa ; Kozuki, Toshiyuki...
Lung Cancer.  184 (2023)  - p. 107349 , 2023
Link: https://doi.org/10.1016/..
 
?
10

First-line nivolumab plus ipilimumab in metastatic non-smal..:

Nishio, Makoto ; Ohe, Yuichiro ; Ikeda, Satoshi...
International Journal of Clinical Oncology.  28 (2023)  10 - p. 1354-1368 , 2023
Link: https://doi.org/10.1007/..
 
?
11

Correction to: Brigatinib in Japanese patients with tyrosin..:

Sugawara, Shunichi ; Kondo, Masashi ; Yokoyama, Toshihide...
International Journal of Clinical Oncology.  28 (2023)  5 - p. 724-725 , 2023
Link: https://doi.org/10.1007/..
 
?
12

Osimertinib as first-line treatment for elderly patients wi..:

Sakata, Yoshihiko ; Saito, Go ; Sakata, Shinya...
Lung Cancer.  186 (2023)  - p. 107426 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Randomized, open-label phase II study of brigatinib and car..:

Wakuda, Kazushige ; Kenmotsu, Hirotsugu ; Sato, Yuki...
BMC Cancer.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
14

IgA vasculitis as an immune-related adverse event of durval..:

Kawataki, Masanori ; Watanabe, Kentaro ; Yokoyama, Toshihide.
Respiratory Investigation.  61 (2023)  2 - p. 205-209 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Correction to: First-line nivolumab plus ipilimumab in meta..:

Nishio, Makoto ; Ohe, Yuichiro ; Ikeda, Satoshi...
International Journal of Clinical Oncology.  28 (2023)  10 - p. 1369-1370 , 2023
Link: https://doi.org/10.1007/..
 
1-15